About
Biologic for Parkinson's
Areas of Focus
Categories
Small Molecule PharmaceuticalFinland
Team (12)
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
1,808
By Phase
PHASE1: 3PHASE1/PHASE2: 3PHASE2: 4PHASE3: 1
By Status
COMPLETED: 10UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06659562Lead Sponsor
Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease
PHASE1Completed
32 participants
Started: Sep 23, 2024 · Completed: Aug 20, 2025
NCT05915247Lead Sponsor
Single Ascending Doses of HER-096 in Healthy Subjects
PHASE1Completed
60 participants
Started: Mar 29, 2023 · Completed: Sep 29, 2023
NCT04228653Collaborator
Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions
PHASE1/PHASE2Unknown
15 participants
Started: Mar 20, 2019 · Completed: Mar 20, 2023
NCT03850626Lead Sponsor
Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients
N/ACompleted
168 participants
Started: Sep 9, 2018 · Completed: Sep 3, 2020
NCT03775538Lead Sponsor
Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
PHASE1/PHASE2Completed
15 participants
Started: Jul 5, 2018 · Completed: Jul 8, 2020
Locations (1)
Headquarters
Espoo, Finland
Map
Loading map...